Samsara BioCapital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Samsara BioCapital’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-318,429	Closed	-$5.28M	–	44
2020 Q2	$5.28M	Buy	318,429 +158,657	+99%	+$2.21M	1.7%	16
2020 Q1	$1.14M	Buy	+159,772	New	+$1.99M	0.66%	25

Samsara BioCapital's PTLA Position: Q3 2020 in Review

Samsara BioCapital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 318,429 shares — an estimated $5.28M sold.

Samsara BioCapital first reported a position in PTLA in Q1 2020 and held it in 2 quarters. The position peaked at $5.28M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Samsara BioCapital reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Samsara BioCapital sold 318,429 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $5.28M.
Samsara BioCapital first reported a position in Portola Pharmaceuticals, Inc. in Q1 2020 and held it in 2 quarters.
Samsara BioCapital's Portola Pharmaceuticals, Inc. position peaked at $5.28M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Samsara BioCapital's 13F filing for Q3 2020, filed 16 Nov 2020.